<DOC>
	<DOCNO>NCT03099044</DOCNO>
	<brief_summary>The purpose pilot study determine effect Single Double Dose Fermented Dairy Beverage immune health inflammatory status healthy adult undergo stressful exercise .</brief_summary>
	<brief_title>`` Fermented Dairy Beverage Inflammation/Immune Function Stressful Exercise ''</brief_title>
	<detailed_description>This `` pilot '' study . A total 45 male subject randomize receive either Active product ( 2 dos ) placebo . This single-blind design ( subject unaware product type receiving ) . Randomization 1:1:1 ratio active test product ( different dos ) versus placebo . Products consume beverage 10-day period . The subject subject define strenuous exercise protocol Days 1 10 study . Blood collect exercise day ( pre- post-exercise ) Days 1 10 . Blood analyze marker Immunity Inflammation , assess immuno-supportive anti-inflammatory property Active product . Product acceptance tolerability also assess use VAS scale . Outcome analysis base upon change time ( time-point 0 ) within group change well group difference . That , study examine difference end-points baseline end-of-study ; well difference among three group .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<criteria>1 . Males , age 18 50 year age ( inclusive ) time screen , nonsmoker least 10 year time screen throughout study . 2 . BMI 20.0 34.9 kg/m2 ( inclusive ) time screen . 3 . Subject currently exercise less 150 minute per week . 4 . Subject good health appropriate exercise determine physical examination , medical history , laboratory test , cardiac monitoring Physical Activity Readiness Questionnaire ( PARQ ) 5 . Subjects must able understand study , agree requirement restriction , willing give voluntary consent participate study . 6 . Subject state able jog , run and/or walk treadmill 60 minute . 1 . History clinically significant cardiovascular ( e.g. , block coronary artery disease , hypertension , hyperlipidemia , WolffParkinsonWhite syndrome , etc . ) , respiratory , endocrine ( e.g. , diabetes I II , etc . ) , renal , hepatic , gastrointestinal , hematologic , neurologic , psychiatric , connective tissue ( e.g. , Marfan syndrome , etc . ) disease disorder , uncontrolled medical illness opinion Investigator would jeopardize safety subject , interfere study assessment , impact validity study result . 2 . Family history first degree relative ( mother , father , sibling , child ) myocardial infarction age 50 first degree relative sudden , unexplained cardiac death . 3 . Subject positive result history positive test result ( ) human immunodeficiency virus ( HIV ) antibody , Hepatitis B surface antigen Hepatitis C antibody . 4 . Subject history cancer ( except localize skin cancer without metastasis ) within five year prior screen . 5 . Subject current orthopedic problem ( ) clinically significant history musculoskeletal injury ( y ) legs PI feel may interfere study exercise . 6 . Subjects deem healthy standard physical , medical history mean screen test ( vitals , blood work , etc . ) per PI review discretion . 7 . Subject currently take take probiotic within 30 day prior baseline visit . 8 . Subjects ingest yogurt ( regular , Greek Icelandic ) , Kefir ferment dairy product four time per week regularly within month prior baseline visit . 9 . Subject regularly consumes fermented beverage , Kombucha . Regular define twice per week twoweeks consistently , within 3 month prior baseline visit . 10 . Subject know suspected allergy hypersensitivity trial product ( ) , include lactose intolerance dairy allergy relate product ( ) . 11 . Subject exhibit evidence hepatic renal dysfunction evidence ALT AST ≥ 2 time upper limit normal serum creatinine value ≥ 2.0 mg/dl clinically significant abnormal clinical laboratory value per PI discretion . 12 . Abnormal electrocardiogram ( ECG ) result think potentially clinically significant accord Investigator , QT prolongation , evidence QTcF &gt; 450 msec . 13 . Subject recent history ( within 12 month Screening ) substance alcohol abuse . 14 . Subject take investigational product within 30 day study enrollment ( Visit 1 ) . 15 . Subject currently take concomitant medication , include prescription counter ( OTC ) , herbal dietary supplement , vitamin and/or mineral supplement , NSAIDS antiinflammatory product , 7 day prior baseline throughout study ( study product ) .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>